SIOUX FALLS, S.D., March 18, 2016 -- Raven Industries (NASDAQ:RAVN) announced today that its board of directors has approved a regular quarterly cash dividend of 13 cents per share. The dividend is payable April 29, 2016, to shareholders of record on April 15, 2016.
About Raven Industries, Inc.
Since 1956, Raven Industries has designed and manufactured high quality, high-value technical products. Raven is publicly traded on NASDAQ (RAVN) and has earned an international reputation for innovation, product quality, high performance, and unmatched service. Raven realizes its vision by developing innovative solutions to great challenges related to the markets we understand and serve. Today, those solutions are focused on feeding and connecting the growing world population, preserving natural resources, and answering the growing need for security. Utilizing our strength in engineering, manufacturing, and technological innovation, Raven is a leader in precision agriculture, high performance specialty films, and situational awareness markets. Visit www.ravenind.com for more information.
CONTACT: Steven Brazones, Chief Financial Officer Raven Industries, Inc. 605-331-0371


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 



